Developing a mild fever after stem cell therapy can be concerning, especially for patients who are unsure what to expect after treatment. The good news is that a temporary low-grade fever is a recognized short-term reaction following certain types of stem cell therapy, particularly after intravenous administration of Umbilical Cord–Derived Mesenchymal Stem Cells (UC-MSCs).
However, not every fever should automatically be considered a normal response. The timing, severity, duration, and any accompanying symptoms all help determine whether the fever is likely to be a temporary treatment-related reaction or a sign that further medical evaluation is needed.
Understanding why fever can occur, what is considered expected, and when to seek medical advice can help patients recover safely and with greater confidence.
Why Can a Fever Occur After Stem Cell Therapy?
A mild fever after UC-MSC therapy is thought to result from the body’s temporary response to the biological activity of the administered cells rather than from an infection.
UC-MSCs interact with the immune system by releasing signaling molecules that help regulate inflammation and support the body’s natural healing process. As a result, some patients may experience a temporary immune response, including a low-grade fever, chills, fatigue, or headache. These symptoms are usually short-lived and reflect the body’s response to treatment rather than harm caused by the cells.
Current evidence also suggests that UC-MSCs do not permanently remain in the body. Instead, they produce their effects through biological signaling before gradually being cleared.
How Common Is Fever After UC-MSC Therapy?
Overall, the available medical evidence suggests that fever is an uncommon but recognized short-term reaction following intravenous UC-MSC therapy.
Across published clinical studies, only a small proportion of patients develop a temporary low-grade fever after treatment. When it occurs, it is generally mild, resolves within a short period, and has not usually been associated with long-term complications when therapy is performed under appropriate medical supervision.
Does Having a Fever Mean the Stem Cells Are Working?
No. This is one of the most common misconceptions surrounding regenerative medicine.
Some patients assume that developing a fever means the stem cells are “activating” or that a stronger reaction indicates a better treatment response. Current scientific evidence does not support this idea. A mild fever is considered a possible treatment-related side effect rather than a marker of treatment success.
Likewise, patients who experience no fever can still respond well to therapy. Every person’s immune system reacts differently, and the absence of symptoms does not mean the treatment has been ineffective.
When Should a Fever Improve?
If a fever is related to stem cell therapy itself, it is generally expected to occur relatively soon after treatment and resolve within a short period.
Some patients may notice feeling slightly warm, tired, or achy during the first day after intravenous treatment. These symptoms often improve with rest, adequate hydration, and routine observation.
There is no exact timeframe that applies to every patient, as recovery depends on individual health, the condition being treated, and the treatment protocol used. However, a fever that continues to worsen, persists for several days, or develops well after treatment should not automatically be attributed to the stem cells.
When Is a Fever Not Considered Normal?
Although mild fever can occur, certain symptoms require prompt medical assessment.
A high fever, persistent fever, or fever accompanied by severe chills, difficulty breathing, chest pain, confusion, persistent vomiting, fainting, widespread rash, or significant weakness should never be assumed to be a normal treatment reaction.
Similarly, patients who develop increasing redness, swelling, severe pain, or discharge around an injection site should be evaluated to rule out infection.
These symptoms may be unrelated to the stem cells themselves and should be assessed by the treating physician or another qualified healthcare professional.
Does the Type of Stem Cell Treatment Matter?
Yes. The likelihood of developing a fever depends partly on how the cells are administered.
Intravenous UC-MSC therapy is more likely to produce temporary whole-body symptoms because the cells enter the bloodstream and interact with the immune system throughout the body.
By comparison, stem cell injections into joints, such as the knee or shoulder, more commonly cause temporary soreness, stiffness, or mild swelling around the treated area. Systemic symptoms such as fever appear to be less common after local joint injections.
For this reason, patients who develop a fever after a joint injection should inform their treating physician, particularly if the affected joint becomes increasingly painful, swollen, warm, or difficult to move.
Does Fever Mean My Body Is Rejecting the Stem Cells?
Not necessarily. UC-MSCs differ from organ transplants and bone marrow transplantation because they are not intended to permanently replace tissues or establish a new immune system.
These cells are generally considered to have low immunogenicity, meaning they are less likely to trigger a strong immune response than many other donor tissues. Rather than permanently integrating into the body, they primarily work by influencing inflammation and supporting the body’s own repair processes through biological signaling.
Scientists continue to study how the immune system interacts with donor-derived MSCs, particularly after repeated treatments. While the immune system can recognize these cells to some degree, a temporary fever alone should not be interpreted as evidence that the body is rejecting the treatment.
What Should You Do If You Develop a Fever?
Patients should carefully follow the post-treatment instructions provided by their medical team.
If the fever is mild and you otherwise feel well, your physician may recommend monitoring your temperature, drinking plenty of fluids, getting adequate rest, and keeping the clinic informed of your symptoms.
However, patients should not ignore a high or persistent fever or assume that every fever is simply part of the healing process. Prompt communication with the treating team allows potential complications to be identified early and managed appropriately.
What Should Patients Expect After Stem Cell Therapy?
Most patients recover from stem cell therapy without developing significant systemic symptoms. When fever does occur, it is usually mild, temporary, and self-limiting. Published clinical evidence suggests that transient fever represents one of several possible short-term reactions following intravenous UC-MSC therapy, but it is not experienced by most patients and should not be viewed as a sign that treatment is either succeeding or failing.
The most important part of recovery is appropriate medical follow-up. Patients should understand what symptoms are expected, which symptoms require medical attention, and when to contact their treating physician. Having clear expectations before treatment helps reduce unnecessary anxiety while ensuring that potentially important symptoms are not overlooked.
Frequently Asked Questions
Is it common to get a fever after stem cell therapy?
A mild fever is a recognized short-term reaction following intravenous UC-MSC therapy, but most patients do not experience one. When it does occur, it is usually temporary and resolves without lasting effects.
Does fever mean the stem cells are working?
No. Current medical evidence does not show that fever predicts treatment success. Some patients develop a mild fever, while many others experience no fever and still respond to treatment.
Should I take medication if I have a fever?
Follow the advice provided by your treating physician. Mild symptoms may only require observation, hydration, and rest, while persistent or worsening fever should be medically assessed before taking medication on your own.
When should I contact my doctor?
You should contact your medical team if your fever is high, continues to worsen, lasts longer than expected, or is accompanied by symptoms such as severe chills, difficulty breathing, chest pain, confusion, increasing joint pain, or significant swelling.
Related Reading
About EDNA Wellness
EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord–Derived Mesenchymal Stem Cells (UC-MSCs).
All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.
For more information or to book a consultation:
LINE: @ednawellness
WhatsApp: +66 (0) 64 505 5599
Website: www.ednawellness.com
References
- Pittenger MF, Discher DE, Peault BM, et al. Mesenchymal Stem Cell Perspective: Cell Biology to Clinical Progress. NPJ Regenerative Medicine. 2019. https://www.nature.com/articles/s41536-019-0083-6
- Wang Y, Chen X, Cao W, Shi Y. Plasticity of Mesenchymal Stem Cells in Immunomodulation: Pathological and Therapeutic Implications. Nature Immunology. 2014. https://www.nature.com/articles/ni.3002
- Meng F, Xu R, Wang S, et al. Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in Patients With COVID-19: A Phase 1 Clinical Trial. Signal Transduction and Targeted Therapy. 2020. https://www.nature.com/articles/s41392-020-00286-5
- Matas J, Orrego M, Amenábar D, et al. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Translational Medicine. 2019. https://academic.oup.com/stcltm/article/8/3/215/6403528
